SKNY Pharmaceuticals
About SKNY Pharmaceuticals
Therapeutics targeting weight loss and smoking cessation are developed by SKNY Pharmaceuticals within the pharmaceutical sector. SKNY-1 is featured as an oral therapy that utilizes CB1 and CB2 pathways to address these conditions. Operations center on advancing treatments for obesity and nicotine addiction. Leadership is held by CEO Erez Aminov, with focus placed on innovative drug development.
-
Sectors
Healthcare
-
Phone
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
-
Acquired by
MIRA Pharmaceuticals
(May 08, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of SKNY Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in SKNY Pharmaceuticals
SKNY Pharmaceuticals has secured backing from 1 investor. Prominent investors backing the company include MIRA Pharmaceuticals. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Cannabinoid-based therapeutics for chronic pain and anxiety are developed.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by SKNY Pharmaceuticals
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - SKNY Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Skny Pharmaceuticals Comparisons
Competitors of SKNY Pharmaceuticals
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about SKNY Pharmaceuticals
Who is the current CEO of SKNY Pharmaceuticals?
Erez Aminov is the current CEO of SKNY Pharmaceuticals.
What does SKNY Pharmaceuticals do?
Therapeutics targeting weight loss and smoking cessation are developed by SKNY Pharmaceuticals within the pharmaceutical sector. SKNY-1 is featured as an oral therapy that utilizes CB1 and CB2 pathways to address these conditions. Operations center on advancing treatments for obesity and nicotine addiction. Leadership is held by CEO Erez Aminov, with focus placed on innovative drug development.
Who are SKNY Pharmaceuticals's investors?
SKNY Pharmaceuticals has 1 investor. Key investors include MIRA Pharmaceuticals.